Dolutegravir and Rifampicin (Rifcap 300 mg Kapsül): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Rifampin induction reduces dolutegravir concentrations.
Clinical significance and safety
Rifampin can reduce dolutegravir exposure. Specialist management depends on treatment history and integrase-inhibitor resistance; do not interrupt HIV or tuberculosis treatment independently.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.